Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia
- PMID: 10589544
Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia
Abstract
A prevalence study of chronic inflammatory demyelinating polyneuropathy (CIDP) was performed in New South Wales (NSW), Australia, with a prevalence day of August 6, 1996, which coincided with a national census. The population of NSW was 5,995,544, and the crude prevalence of CIDP was 1.9 per 100,000 population. It was higher in male patients than in female patients, and the age-specific prevalence reached a maximum of 6.7 per 100,000 population in the 70- to 79-year-old age group. The prevalence in the city of Newcastle, with a population of 448,663, was 2.0 per 100,000 population and is representative of the whole of NSW. The estimated crude annual incidence was 0.15 per 100,000 population. The mean age of onset was 47.6 years (median, 53.5 years), 51% of patients had a relapsing-remitting course, the mean duration on prevalence day was 7.1 years (median, 5 years), and 87% of patients were able to walk without walking aids or other assistance.
Similar articles
-
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.Med J Aust. 1994 Feb 7;160(3):117-22. Med J Aust. 1994. PMID: 8295576
-
Retinoblastoma in New South Wales 1975 to 2001.J Pediatr Hematol Oncol. 2006 Oct;28(10):642-6. doi: 10.1097/01.mph.0000212983.51867.46. J Pediatr Hematol Oncol. 2006. PMID: 17023823
-
[Estimation of the future epidemiological situation of tuberculosis in Japan].Kekkaku. 2008 Apr;83(4):365-77. Kekkaku. 2008. PMID: 18516900 Japanese.
-
The rising incidence of childhood type 1 diabetes in New South Wales, 1990-2002.Med J Aust. 2005 Sep 5;183(5):243-6. Med J Aust. 2005. PMID: 16138797
-
A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.J Neurol Sci. 2007 Apr 15;255(1-2):1-6. doi: 10.1016/j.jns.2007.01.004. Epub 2007 Feb 15. J Neurol Sci. 2007. PMID: 17306302
Cited by
-
Spinal canal decompression for hypertrophic neuropathy of the cauda equina with chronic inflammatory demyelinating polyradiculoneuropathy: A case report.World J Clin Cases. 2022 May 6;10(13):4294-4300. doi: 10.12998/wjcc.v10.i13.4294. World J Clin Cases. 2022. PMID: 35665127 Free PMC article.
-
FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.J Neuroinflammation. 2019 Mar 2;16(1):54. doi: 10.1186/s12974-019-1441-4. J Neuroinflammation. 2019. PMID: 30825874 Free PMC article.
-
Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy.Indian J Anaesth. 2011 May;55(3):277-9. doi: 10.4103/0019-5049.82683. Indian J Anaesth. 2011. PMID: 21808402 Free PMC article.
-
A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1.J Korean Neurosurg Soc. 2014 Jun;55(6):370-4. doi: 10.3340/jkns.2014.55.6.370. Epub 2014 Jun 30. J Korean Neurosurg Soc. 2014. PMID: 25237436 Free PMC article.
-
Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy.J Neuroinflammation. 2021 Apr 8;18(1):89. doi: 10.1186/s12974-021-02130-1. J Neuroinflammation. 2021. PMID: 33832507 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources